VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ — Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum Significant events in the second quarter of 2025 FDA PMA Submission Completed – Submitted third and final module of the U.S. FDA pre-market approval (PMA)…
